Literature DB >> 19382314

Murine mast cells secrete a unique profile of cytokines and prostaglandins in response to distinct TLR2 ligands.

Salima Mrabet-Dahbi1, Martin Metz, Anne Dudeck, Torsten Zuberbier, Marcus Maurer.   

Abstract

Mast cells (MCs) are important effector cells in host defense against bacteria. In the course of a bacterial infection, MCs can be activated by various mechanisms, i.e. bacterial toxins, endogenously produced infection-associated peptides or via complement receptors, fimbrial adhesion molecules and toll-like receptors (TLRs). While some of these mechanisms are well established, the effects of TLR2 ligand-driven MC activation are far less understood. Here, we show that murine mature connective tissue-type MCs, but not immature bone marrow-derived cultured mast cells, express significant amounts of full length TLR2 on their surface. Activation by various TLR2 ligands only induces the selective release of cytokines in peritoneum-derived cultured mast cells (PCMCs) with preferential secretion of pro-inflammatory cytokines (IL-6 > IL-17 > IFN-gamma TNF > IL-1 > GM-CSF) upon stimulation with lipoteichoic acid (LTA). This response is much lower in PCMCs stimulated with the TLR2/6 agonist macrophage-activating lipopeptide-2 (MALP-2), which most prominently triggers the release of the immunomodulatory cytokine IL-10. Furthermore, only LTA but not MALP-2 induces prostaglandin D2 secretion which is again restricted to the mature MC phenotype. These findings suggest that TLR2 ligand-mediated activation of mature MCs, i.e. tissue-residing cells, which most likely occurs during infection, can selectively raise a potent inflammatory or anti-inflammatory response, depending on TLRs which are engaged.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19382314     DOI: 10.1111/j.1600-0625.2009.00878.x

Source DB:  PubMed          Journal:  Exp Dermatol        ISSN: 0906-6705            Impact factor:   3.960


  39 in total

1.  Commensal bacteria lipoteichoic acid increases skin mast cell antimicrobial activity against vaccinia viruses.

Authors:  Zhenping Wang; Daniel T MacLeod; Anna Di Nardo
Journal:  J Immunol       Date:  2012-07-06       Impact factor: 5.422

Review 2.  The role of Toll-like receptors in renal diseases.

Authors:  Anna Gluba; Maciej Banach; Simon Hannam; Dimitri P Mikhailidis; Agata Sakowicz; Jacek Rysz
Journal:  Nat Rev Nephrol       Date:  2010-02-23       Impact factor: 28.314

3.  Mast cells cultured from IL-3-treated mice show impaired responses to bacterial antigen stimulation.

Authors:  Krisztina V Vukman; Tamás Visnovitz; Paul N Adams; Martin Metz; Marcus Maurer; Sandra M O'Neill
Journal:  Inflamm Res       Date:  2011-11-09       Impact factor: 4.575

4.  Infection of mast cells with live streptococci causes a toll-like receptor 2- and cell-cell contact-dependent cytokine and chemokine response.

Authors:  Elin Rönnberg; Bengt Guss; Gunnar Pejler
Journal:  Infect Immun       Date:  2009-11-23       Impact factor: 3.441

Review 5.  Potential effector and immunoregulatory functions of mast cells in mucosal immunity.

Authors:  L L Reber; R Sibilano; K Mukai; S J Galli
Journal:  Mucosal Immunol       Date:  2015-02-11       Impact factor: 7.313

6.  The dual nature of T(H)17 cells: shifting the focus to function.

Authors:  William O'Connor; Lauren A Zenewicz; Richard A Flavell
Journal:  Nat Immunol       Date:  2010-05-18       Impact factor: 25.606

7.  Inhibiting mast cell degranulation by HO-1 affects dendritic cell maturation in vitro.

Authors:  Yuan-yuan Ma; Mu-qing Yang; Chun-feng Wang; Jing Ding; Ji-yu Li
Journal:  Inflamm Res       Date:  2014-03-07       Impact factor: 4.575

8.  The role of SHIP in the development and activation of mouse mucosal and connective tissue mast cells.

Authors:  Jens Ruschmann; Frann Antignano; Vivian Lam; Kim Snyder; Connie Kim; Martha Essak; Angela Zhang; Ann Hsu-An Lin; Raghuveer Singh Mali; Reuben Kapur; Gerald Krystal
Journal:  J Immunol       Date:  2012-03-19       Impact factor: 5.422

Review 9.  Targeting IL-17 and TH17 cells in chronic inflammation.

Authors:  Pierre Miossec; Jay K Kolls
Journal:  Nat Rev Drug Discov       Date:  2012-10       Impact factor: 84.694

Review 10.  The role of eosinophils and mast cells in intestinal functional disease.

Authors:  Marjorie M Walker; Alasdair Warwick; Chuin Ung; Nicholas J Talley
Journal:  Curr Gastroenterol Rep       Date:  2011-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.